 产品搜索 |
| 产品类别 |
| 推荐产品 |
 叔丁基二甲基氯硅烷 |
| 2-氯-4,6-二甲基吡啶 |
| 2-溴-4,6-二甲基吡啶 |
| 6-氯苯并三氮唑-1,1,3,3- |
| 1,3-二苯基异苯并呋喃 |
| 培哚普利 |
| 9-(4-乙酰氧基-3-乙酰氧 |
| 嘧啶-5-硼酸 |
| 2-氯-3-硝基-4-甲基吡啶 |
| 7-氮杂吲哚 |
| 4-氮杂吲哚 |
| 5-氮杂吲哚 |
| 6-氮杂吲哚 |
| 7-azaoxindole |
| 6-azaoxindole |
| 4-叔丁基苯硼酸 |
| D-氨基半乳糖盐酸盐 |
| N-乙酰基-D-氨基半乳糖 |
| 溴代葡萄糖苷 |
| 利培酮 |
| N-三氟乙酰基-L-赖氨酸 |
| N2-(1-乙氧羰基-3-苯丙基 |
| N2-[1-(S)-乙氧羰基-3-苯 |
| 3-氨基甲酰基苯硼酸 |
| 2,4-二氯-6-甲基嘧啶 |
| N-(4-氨基丁基)-N-乙基异 |
| AOP |
| BOP |
| 4,4-二甲氧基三苯甲基 |
| 2-氯-1-甲基吡啶碘盐 |
| HOTT |
| TSTU |
| 1-(4-甲磺基)-3-硝基-1,2,4 |
| TPTU |
| 2,4,6-三异丙基苯磺酰氯 |
| TOTU |
| TOTT |
| TNTU |
| TFFH |
| TDBTU |
| TCTU |
| TCFH |
| TBTU |
| TATU |
| N-Hydroxysulfosuccinimide sodi |
| 8-喹啉磺酰氯 |
| PyCloP |
| PYCLU |
| PyBroP |
| PyBOP |
|
| 产品展示 |
| 产品编号 |
产品名称 |
CAS No. |
含量 |
| NNXMY1672865934973 | Pyridazine, 3-(3-bromophenoxy)- | 40890-12-8 | |
| NNXMY1672865934974 | 1,1-Dimethylethyl N-(5-hydroxy-2-pyrimidinyl)carbamate | 1951444-51-1 | |
| NNXMY1672865934975 | 4-[1-Methyl-1-(1-methylethoxy)ethyl]-2-thiazolamine | 2293131-41-4 | |
| NNXMY1672865934976 | 4-Bromo-2-(methoxymethyl)thiazole | 1401997-31-6 | |
| NNXMY1672865934977 | N-(1-Methylethyl)-6-(tributylstannyl)-2-pyrazinamine | 1401349-75-4 | |
| NNXMY1672865934978 | 3-(4-Cyclopropyl-2-pyrimidinyl)-5-(5-phenyl-1,3,4-oxadiazol-2-yl)-1H-indole | 1401347-79-2 | |
| NNXMY1672865934979 | 6-[5-(5-Amino-1,3,4-thiadiazol-2-yl)-1H-indol-3-yl]-N-cyclohexyl-2-pyrazinamine | 1401347-31-6 | |
| NNXMY1672865934980 | 6-[5-(5-Amino-1,3,4-thiadiazol-2-yl)-1H-indol-3-yl]-N-(1-methylethyl)-2-pyrazinamine | 1401347-29-2 | |
| NNXMY1672865934981 | 6-[5-(5-Amino-1,3,4-thiadiazol-2-yl)-1H-indol-3-yl]-N-cyclohexyl-2-pyridinamine | 1401347-28-1 | |
| NNXMY1672865934982 | 6-[5-(5-Amino-1,3,4-thiadiazol-2-yl)-1H-indol-3-yl]-2-pyridinamine | 1401347-13-4 | |
| NNXMY1672865934983 | 5-[3-[6-(1-Pyrrolidinyl)-2-pyrazinyl]-1H-indol-5-yl]-1,3,4-thiadiazol-2-amine | 1401347-12-3 | |
| NNXMY1672865934984 | 5-[3-[6-(Cyclohexyloxy)-2-pyridinyl]-1H-indol-5-yl]-1,3,4-thiadiazol-2-amine | 1401346-98-2 | |
| NNXMY1672865934985 | 5-[3-(6-Ethoxy-2-pyridinyl)-1H-indol-5-yl]-1,3,4-thiadiazol-2-amine | 1401346-89-1 | |
| NNXMY1672865934986 | 5-[3-[6-(Cyclopentyloxy)-2-pyridinyl]-1H-indol-5-yl]-1,3,4-thiadiazol-2-amine | 1401346-88-0 | |
| NNXMY1672865934987 | 5-[3-[6-(Cyclopentyloxy)-2-pyrazinyl]-1H-indol-5-yl]-1,3,4-thiadiazol-2-amine | 1401346-85-7 | |
| NNXMY1672865934988 | 5-[3-[6-(1-Methylethoxy)-2-pyrazinyl]-1H-indol-5-yl]-1,3,4-thiadiazol-2-amine | 1401346-84-6 | |
| NNXMY1672865934989 | 5-[3-[6-(4-Morpholinyl)-2-pyrazinyl]-1H-indol-5-yl]-1,3,4-thiadiazol-2-amine | 1401346-81-3 | |
| NNXMY1672865934990 | 5-[3-(4-Phenyl-2-pyrimidinyl)-1H-indol-5-yl]-1,3,4-oxadiazol-2-amine | 1401346-48-2 | |
| NNXMY1672865934991 | 5-[3-(4-Phenoxy-2-pyrimidinyl)-1H-indol-5-yl]-1,3,4-oxadiazol-2-amine | 1401346-32-4 | |
| NNXMY1672865934992 | 5-[3-(6-Cyclopropyl-2-pyrazinyl)-1H-indol-5-yl]-1,3,4-oxadiazol-2-amine | 1401346-25-5 | |
| NNXMY1672865934993 | 5-[3-(4-Cyclopropyl-2-pyrimidinyl)-1H-indol-5-yl]-1,3,4-oxadiazol-2-amine | 1401346-21-1 | |
| NNXMY1672865934994 | 5-[3-(2-Pyrimidinyl)-1H-indol-5-yl]-1,3,4-oxadiazol-2-amine | 1401346-20-0 | |
| NNXMY1672865934995 | 5-[3-(3-Quinolinyl)-1H-indol-5-yl]-1,3,4-thiadiazol-2-amine | 1401345-27-4 | |
| NNXMY1672865934996 | 5-[3-(6-Ethoxy-2-pyrazinyl)-1H-indol-5-yl]-1,3,4-thiadiazol-2-amine | 1401345-25-2 | |
| NNXMY1672865934997 | 5-[3-[6-(1-Pyrrolidinyl)-2-pyridinyl]-1H-indol-5-yl]-1,3,4-thiadiazol-2-amine | 1401345-18-3 | |
| NNXMY1672865934998 | 4-Chloro-6-[(4-methoxyphenyl)methoxy]-2-(methylsulfonyl)pyrimidine | 1380918-72-8 | |
| NNXMY1672865934999 | 3-Fluoro-2-methyl-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine | 952403-32-6 | |
| NNXMY1672865935000 | N-(2′,4′-Dimethyl[4,5′-bithiazol]-2-yl)-3-pyridinamine | 708996-29-6 | |
| NNXMY1672865935001 | 1-Methyl-4-[6-(tributylstannyl)-2-pyridinyl]piperazine | 474711-53-0 | |
| NNXMY1672865935002 | N-(4-Methoxyphenyl)-2′,4′-dimethyl[4,5′-bithiazol]-2-amine | 315705-51-2 | |
|
|
|
|
